The quality of diagnostic samples;Die qualität diagnostischer proben

LaboratoriumsMedizin

Volumn 26, Issue 5-6, 2002, Pages 267-283

  Guder, Walter G ^a   Ehret, W ^a   Da Fonseca Wollheim, F ^a   Heil, W ^a   Muller Plathe O ^a   Schmitt, Y ^a   Topfer G ^a   Wisser, H ^a   Zawta, B ^a   Banfi, G ^a   Becker, C ^a   Brand, W ^a   Buchberger, M ^a   Deom, A ^a   Engel, W D ^a   Fraser, C G ^a   Friemert, V J ^a   Golf, S ^a   Gross, H ^a   Gunzer, G ^a   Hagemann, P ^a   Heins, M ^a   Henny, J ^a   Hinzmann, R ^a   Hoffmann, G ^a   Kallner, A ^a   Kitta, H ^a   Klahr, D ^a   Kolpe, D ^a   Kukuk, J ^a   Kunert Latus, T ^a   Lammers, M ^a   Leppanen E A ^a   Mikulcik, P ^a   Narayanan, S ^a   Neumaier, M ^a   Peca Amaral Gomes M A ^a   Probst, R ^a   Sonntag, O ^a   Weisheit, R ^a   Zinck, R ^a   more..

^a KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CYCLODEXTRIN; BILIRUBIN; CITRIC ACID; DRUG; EDETIC ACID; HEPARIN; HIRUDIN; IMMUNOLOGIC AGENT; MACROGOL; PROTEIN;

ANTICOAGULATION; ARTICLE; CHEMICAL ANALYSIS; GOOD LABORATORY PRACTICE; HEMOLYSIS; LABORATORY; PLASMA; SAMPLE; SERUM; TOTAL QUALITY MANAGEMENT; URINE;

EID: 1642342848     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0477.2002.02036.x     Document Type: Article

References (104)

1. Richtlinie der bundesärztekammer zur qualitätssicherung quantitativer laboratoriumsmedizinischer untersuchungen
2. Single-use receptacles for human venous blood specimen collection
3. Stabilität der meßgrößen in der Proben-matrix
4. Wahl des optimalen probenvolumens
5. Serum, plasma or whole blood? Which anticoagulants to use?
6. The haemolytic, icteric and lipemic sample. Recommendations regarding their recognition and prevention of clinically relevant interferences
7. 3-EDTA: The anticoagulant of choice in routine haematology?
8. Pre-analytical phase in haemostasis
9. Effects of 3.2 % vs. 3.8 % citrate concentration on routine coagulation testing
10. Einfluß der citratkonzentration in blutentnahmeröhrchen auf hämostaseologische meßgrößen
11. Approved IFCC recommendations on whole blood sampling, transport, and storage for simultaneous determination of pH, blood gases, and electrolytes
12. Modulation of blood cell activation by four commonly used anticoagulants
13. Die beeinflussung von gerinnungstesten durch rekombinantes hirudin
14. Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics
15. Current databases on biological variation: Pros, cons and progress
16. The effect of the order of filling tubes after venipuncture on serum potassium, total protein, and aspartate and alanine aminotransferase
17. Phlebotomy - A minimalist approach
18. Phlebotomy for diagnostic laboratory tests in adults: Pattern of use and effect on transfusion requirements
19. Serum-index und interferogramm - Ein neuer weg zur prüfung und darstellung von interferenzen durch serumchromogene
20. Interference-reduced methodologies for Boehringer Mannheim/Hitachi analyzers: Validation using recombinant haemoglobin "blood substitute" product
21. Haemolysis as an influence and interference factor in clinical chemistry
22. In vitro effects of a novel haemoglobin-based oxygen carrier on routine chemistry, therapeutic drug, coagulation, hematology, and blood bank assays
23. Multiple regression analysis of interference effects from a haemoglobin-based-oxygen carrier solution
24. Effect of the haemoglobin-based oxygen carrier HBOC-201 on laboratory instrumentation: Cobas Integra, Chiron blood gas analyzer 840, Sysmex™ SE-9000 and BCT
25. Hemoglobin interference from in vivo hemolysis
26. The influence of bilirubin, haemolysis and turbidity on 20 analytical tests performed on automatic analysers
27. Determination of free haemoglobin in serum by automated assay using 4-aminophenazone and the Cobas Bio system
28. Evaluation of a nephelometric assay for haptoglobin and its clinical usefulness
29. Einflußgrößen und störgrößen
30. Elimination of interference by hemoglobin-based oxygen carriers (HBOC) in clinical laboratory tests
31. Creatinekinase in serum: 2. Interference of adenylate kinase with the assay
32. Studies on the interference by haemoglobin in the determination of bilirubin
33. Haemolysis as an interference factor in clinical chemistry
34. Serum ultrafiltration for the elimination of endogenous interfering substances in creatinine determination
35. Problems with measurements caused by high concentrations of serum lipids
36. Determination of electrolytes in serum and derum water
37. Flocculation of serum lipoproteins with cyclodextrin: Application to assay of hyperlipidemic serum
38. Klärung lipäimischer seren durch ein neues verfahren
39. Simple removal of lipids from serum
40. Sample quality
41. Evaluation of four reagents for delipidation of serum
42. Characterization of a new ion selective electrode for ionized magnesium in whole blood, plasma, serum, and aqueous samples
43. Interference due to lipaemia in routine photometric analysis - survey of an underrated problem
44. Different effects of Intralipid™ and triacylglycerol rich lipoproteins on Kodak Ektachem serum cholesterol determination
45. Lipaemic interference: Effects of lipaemic serum and Intralipid
46. Interferenzen durch lipämie, hämolyse und hyperbilirubinämie am DAX 48-analysator und ihre klinische relevanz
47. Liver function
48. Ringstudie zur bilirubininterferenz bei der bestimmung von serum-kreatinin
49. Analytisch und klinisch relevante Interferenzen in der Gerinnungsanalytik am Beispiel des MDA 180
50. Pseudohypophosphataemia as a result of bilirubin interference
51. Bilirubin interference with determination of uric acid, cholesterol, and triglycerides in commercial peroxidase-coupled assays
52. The estimation of plasma albumin by BCG dye binding on the Technicon SMA 12/60
53. Bilirubin interference in a peroxidase-coupled procedure for creatinine eliminated by bilirubin oxidase
54. Ultrafiltrate analysis confirms the specificity of the selected method for plasma ammonia determination
55. Dilution of citrated plasma
56. Storage of serum or whole blood samples?fsti Effect of time and temperature on 22 serum analytes
57. Stability of routine chemistry parameters in lithium heparin gel tubes
58. Untersuchungen zur stabilität von 11 serumproteinen bei bestimmung mit immunturbidimetrie
59. Overestimation of albumin in heparinized plasma
60. Influence of preanalytical factors on the atomic absorption spectrometry determination of trace elements in biological samples
61. Guidelines for therapeutic drug monitoring services
62. Deamidation of glutamine by increased plasma -glutamytransferase is a source of rapid ammonia formation in blood and plasma specimens
63. Approved recommendation on IFCC methods for the measurements of catalytic concentration of enzymes. Part 9. IFCC method for -amylase (1,4-D-glucan 4-glucanohydrolase, EC 3.2.1.1)
64. Einfluß von lagerung und temperatur auf die anaylse von steroiden in plasma und blut
65. Influence of time and temperature on coagulation analytes in stored plasma
66. Determination of coagulation parameters in citrated venous blood, catheter blood, and capillary blood: Preanalytical problems
67. EinfluB der citratkonzentration in blutentnahmer6hrchen auf hämostaseologische meßgrößen
68. Preanalytical, including biological variation in lipid and apolipoprotein measurements
69. Effect of storage at 4 °C and -20 °C on lipid, lipoprotein, and apoprotein concentrations
70. Effect of short- or long-term storage on human serum and recombinant apolipoprotein E concentration
71. Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: The ApoEurope study
72. The preanalytical phase. An important component of laboratory medicine
73. Immunoradiometry assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma
74. Stability of human natriuretic peptide in blood sample
75. 1-mikroglobulin und retinol-bindendem protein im urin mit dem behring nephelometer system (BNS)
76. Effect of storage time, temperature and preservative on IgG, transferrin, albumin and alpha-1-microglobulin levels in urine
77. Lomg-term stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain immunoreactivity, orosomucoid and alpha-1-antitrypsin in urine stored at -20 °C
78. Stability of drugs of abuse in urine samples stored at -20 °C
79. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones
80. Stability of drugs of abuse in biological specimens
81. Diagnostische bedeutung der lactatbestimmung im liquor bei meningitis
82. Liquordiagnostik: Klinisch-chemische kenngrößen: Eine kritische bilanz